Abstract
AbstractContrast-enhanced ultrasound (CEUS) has been widely accepted as a diagnostic tool for the detection and evaluation of benign and malignant liver lesions and has been implemented into the clinical routine as a tool for percutaneous interventional real-time image guidance. CEUS can be combined with computed tomography (CT) and magnetic resonance imaging (MRI) datasets using real-time image fusion to additionally surveil proper interventional treatment and assess treatment success. This review describes the state-of-the-art use of CEUS for the surveillance and monitoring of interventional procedures of the liver and for the evaluation of postinterventional success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
